![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ondine Biomed | LSE:OBP | London | Ordinary Share | CA68234M1068 | COM SHS NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMOBP Circ re: Ondine Biopharma Corporation ("Ondine Biopharma" or the "Company") Publication of Information Circular and Mail Out of Financial Statements, MD&A and Shareholder Meeting Materials FOR: ONDINE BIOPHARMA CORPORATION TSX, AIM SYMBOL: OBP May 20, 2010 Ondine Biopharma Corporation ("Ondine Biopharma" or the "Company") Publication of Information Circular and Mail Out of Financial Statements, MD&A and Shareholder Meeting Materials VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 20, 2010) - Ondine Biopharma (TSX:OBP)(AIM:OBP) announces that, in accordance with regulatory requirements, it has mailed out its Financial Statements and Management Discussion and Analysis (MD&A) for the year ended December 31, 2009 as well as its Information Circular, Notice of Meeting and related proxy materials on May 19, 2010, in connection with the Company's annual general and special meeting to be held on Thursday, June 17, 2010 at 10:00 A.M. (the "Meeting") at the Company's office at 910-1100 Melville Street, Vancouver, British Columbia, Canada. Copies of these documents are available during normal business hours on weekdays (except Saturdays, Sundays and public holidays) free of charge from the Company's office at 910-1100 Melville Street, Vancouver, British Columbia, Canada. In addition, these documents are available on the SEDAR website at www.sedar.com and on the Company's website at www.ondinebiopharma.com. -30- FOR FURTHER INFORMATION PLEASE CONTACT: Ondine Biopharma Corporation Carolyn Cross Chairman and Chief Executive Officer (604) 669-0555 ccross@ondinebiopharma.com www.ondinebiopharma.com OR Canaccord Genuity Limited Ryan Gaffney Nominated Adviser +4420 7050 6500 Ondine Biopharma Corporation
1 Year Ondine Biomed Chart |
1 Month Ondine Biomed Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions